Join Senior Leaders from Top Biotech & Pharma Companies
|
|
|
Fierce JPM Week is just two weeks away on January 9-10th in San Francisco and a who's who in Pharma and Biotech will be coming together to share their experiences, insights and thoughts on the upcoming year's hottest topics. Join over 500 senior biotech and pharma executives at this one-of-a-kind event focused on learning, networking and connecting. VIEW THE AGENDA>> Time is running out and limited passes are left! Register now to secure your spot. |
|
|
Check Out This Snapshot of Companies Already Registered: |
|
|
| AbbVieAbdera TherapeuticsAchelois BioPharmaAdvanced Interactive Interactive ResponseAlkermesAllogeneAlphaSenseAndreessen HorowitzAntiva BiosciencesAprecia PharmaceuticalsAptar Digital HealthArbor BiotechnologiesArdelyxAstellas PharmaAstraZeneca Avenzo TherapeuticsAWSBayerBeam TherapeuticsBeta PharmaBiocytogenBioLineRxBioMarin PharmaceuticalBioPhy BioQuestBiorchestraBlue AnthemBlueprint MedicinesBP LogixBristol Myers SquibbCanaanCanary GlobalCellinoCerevel TherapeuticsCognizantCosmica IncCytoAgents |
| | Daiichi SankyoDeepIntentDenovo BiopharmaDynavaxEli LillyEmendoBioEnneta TherapeuticsEurofins CDMO AlphoraEvotecExpansion TherapeuticsFrontier Medicines GileadGlobal Health InvestH1IDA Irelandidentifeye HEALTHIncyteIQVIAJ&JJust-Evotec BiologicsKAER BiotherpeuticsKite PharmaKognitic IncKomodo HealthKura OncologyKymanoxLarkspur Bioscience Loxo@LillyLytix Biopharma ASMarina Maher CommunicationsMedicovestorMelinta TherapeuticsMerckMultitude TherapeuticsNalu BioNeRRe TherapeuticsNeukio Biotherapeutics |
| NovartisNucleus RadiopharmaNuvora OracleOrientation MarketingPhRMAPluvia BiotechPorter NovelliPrendio LLCPrototkinetixPTC TherapeuticsPwC Ray TherapeuticsReCode TherapeuticsRetro BioRocheSalesforceSarcomatrix TherapeuticsSilicon Valley BankSlalom SmartLabsSofinnova InvestmentsStructure TherapeuticsSumitomo PharmaSurgo HealthSyneos HealthTakedaTeiko.bio Teva PharmaceuticalsTevard BiosciencesThiogenesis Therapeutics
uBriGene BiosciencesUltragenyx PharmaceuticalVir BiotechnologyViz.aiWaterhouse BrandsWeber Shandwick |
|
|
| Crossovers, Megarounds and IPOs: Biotechs Always Find a WayExploring the Inflation Reduction Act: Pharma's Legal Battles and the Future of InnovationA Look at Biopharma M&A and Shifting Deal Dynamics Advancements and Challenges in Cell & Gene Therapy ManufacturingOncology's Next Frontier: ADCs, Radiopharma and the Future of Cancer TreatmentRevolutionizing Healthcare: The Impact of AI Disruption in Clinical Trials |
Johanna Mercier, Chief Commercial Officer, GileadKate Haviland, Chief Executive Officer, Blueprint Medicines Marianne De Backer, Chief Executive Officer and Director, Vir Biotechnology
Robert Plenge, EVP, Chief Research Officer, Head of Research, Bristol-Myers Squibb Daejin Abidoye, Vice President, Therapeutic Area Head Solid Tumor, AbbieVieIssei Tsukamoto, SVP and Head of Global Business Development, Astellas Pharma Inc. Elizabeth Naldi Jacob, Head of Oncology BD & Headquarters Transactions, MerckChris McDonald, SVP and Global Head of Technical Operations, Kite Pharma Morten Sogaard, President and Division Head of Research and Technical Operations, Astellas Gene Therapies |
|
|
Don't Miss the Complimentary Virtual Event
January 16-18, 2024 |
|
|
Your All-Access Pass will also give you access to our companion virtual event on Jan. 16-18 where you will hear our editorial staff interview prominent executives from Vir Biotechnology, BMS, ReCode Therapeutics, Gilead, Sumitomo, Bayer, and more! PLUS, you'll be able to catch up on all the recorded live sessions. If you're not able to join us in-person, then please be sure to check out our virtual-only option. |
| |
|
Thank You to Our Partners |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017 Contact Us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
|
